News
During a live event, Steven I. Robinson, MBBS, discussed desmoid tumor statistics and management for symptomatic progression.
Researchers explore talquetamab as a bridge therapy for multiple myeloma patients before CAR T-cell treatment, assessing safety and efficacy outcomes.
Experts explore innovative bridging therapies for multiple myeloma, enhancing patient outcomes before CAR T-cell treatment while addressing significant challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results